Home / Biopharma / Stocks Sparking Bullish Stampede across Wall Street: Medivation (NASDAQ:MDVN), Celldex Therapeutics (NASDAQ:CLDX)

Stocks Sparking Bullish Stampede across Wall Street: Medivation (NASDAQ:MDVN), Celldex Therapeutics (NASDAQ:CLDX)

Medivation, Inc. (NASDAQ:MDVN) persists its position slightly strong in context of selling side, shares remains unchanged to $81.44. EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at 25.70%, and looking further price to next year’s EPS is 76.40%. While take a short look on price to sales ratio, that was 13.16

Teacher Retirement System of Texas surged its position in Medivation Inc. (MDVN) by 31.2% during the q2, Holdings Channel reports. The firm owned 11,695 shares of the biopharmaceutical firm’s stock following buying an additional 2,780 shares during the period. Teacher Retirement System of Texas’ holdings in Medivation were worth $705,000 at the end of the most recent reporting period.

Medivation (NASDAQ:MDVN) last posted its earnings results on Tuesday, August 9th. The biopharmaceutical firm reported $0.29 eps (EPS) for the quarter, topping analysts’ consensus anticipates of $0.27 by $0.02. Medivation had a positive return on equity of 17.57% and a negative net margin of 17.24%. The business earned $206 million during the quarter as compared to analysts’ expectations of $214.52 million. During the same period in the previous year, the business earned $0.58 EPS. Medivation’s income for the quarter was up 17.4% compared to the same quarter previous year. Equities analysts expect that Medivation Inc. will post $1.27 EPS for the current fiscal year.

Following previous ticker characteristics, Celldex Therapeutics, Inc. (NASDAQ:CLDX) also run on active notice, stock price increased 6.32% after traded at $4.04 in most recent trading session.

CLDX price to current year EPS stands at 0.80%. Whereas the traders who further want to see about this, may be interested to see Price to next year’s EPS that would be 8.20%. Moving toward ratio analysis, it has current ratio of 11.40 and quick ratio was calculated as 11.40. The debt to equity ratio appeared as 0.00 for seeing its liquidity position.

Taking notice on volatility measures, price volatility of stock was 8.39% for a week and 5.57% for a month. The price volatility’s Average True Range for 14 days was 0.22. On these bases, analysts would recommend this stock as an “Active Revolving Stocks.” The firm attains analyst recommendation of 2.20 out of 1-5 scale with week’s performance of 5.48%. CLDX’s institutional ownership was registered as 79.60%, while insider ownership was 0.50%.


About Richard Avery

He is a capital projects manager and process design engineer at a large-cap company. He has renowned MBA degree. Before joining SWR, he was a freelance writer for renounce tech websites. He is currently studying for CFP exam. Interests: Tech stocks, Economic Markets, Blue-chips.

Check Also

Analysts Forecasting Profitability Indicators: Aetna Inc. (NYSE:AET), ZIOPHARM Oncology (NASDAQ:ZIOP)

To stick with focus on profitability valuation, Aetna Inc. (NYSE:AET) also listed in significant eye …

Leave a Reply

Your email address will not be published. Required fields are marked *